Travere Therapeutics (TVTX) Short Interest Ratio & Short Volume $15.84 +0.14 (+0.89%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$15.92 +0.07 (+0.47%) As of 05/23/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Travere Therapeutics Short Interest DataTravere Therapeutics (TVTX) has a short interest of 10.64 million shares. This marks a -3.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 1.57 million shares to cover all short positions.Current Short Interest10,640,000 sharesPrevious Short Interest11,050,000 sharesChange Vs. Previous Month-3.71%Dollar Volume Sold Short$221.42 millionShort Interest Ratio5.7 Days to CoverLast Record DateApril 30, 2025Outstanding Shares88,805,000 sharesPercentage of Shares Shorted11.98%Today's Trading Volume1,433,214 sharesAverage Trading Volume1,574,465 sharesToday's Volume Vs. Average91% Short Selling Travere Therapeutics? Sign up to receive the latest short interest report for Travere Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTVTX Short Interest Over TimeTVTX Days to Cover Over TimeTVTX Percentage of Float Shorted Over Time Travere Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202510,640,000 shares $221.42 million -3.7%N/A5.7 $20.81 4/15/202511,050,000 shares $164.76 million -4.4%14.7%6.2 $14.91 3/31/202511,560,000 shares $207.16 million +3.3%15.4%6.6 $17.92 3/15/202511,190,000 shares $220.78 million +2.2%14.9%7 $19.73 2/28/202510,950,000 shares $234.33 million -3.1%14.6%7.2 $21.40 2/15/202511,300,000 shares $258.88 million +18.2%15.0%7.7 $22.91 1/31/20259,560,000 shares $195.60 million -0.2%N/A6.8 $20.46 1/15/20259,580,000 shares $173.11 million +9.9%N/A7.4 $18.07 12/31/20248,720,000 shares $151.90 million +17.7%N/A5.9 $17.42 12/15/20247,410,000 shares $128.34 million -2.1%N/A4.5 $17.32 Get the Latest News and Ratings for TVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20247,570,000 shares $142.39 million +8.6%N/A4.3 $18.81 11/15/20246,970,000 shares $123.51 million -12.8%N/A3.6 $17.72 10/31/20247,990,000 shares $139.83 million -1.5%N/A4.4 $17.50 10/15/20248,110,000 shares $143.47 million +16.5%N/A4.7 $17.69 9/30/20246,960,000 shares $97.37 million -19.6%N/A4.2 $13.99 9/15/20248,660,000 shares $116.74 million -6.4%N/A6.2 $13.48 8/31/20249,250,000 shares $87.60 million -0.5%N/A7.2 $9.47 8/15/20249,300,000 shares $81.65 million -7.8%N/A8.5 $8.78 7/31/202410,090,000 shares $96.26 million -0.1%N/A8.8 $9.54 7/15/202410,100,000 shares $99.08 million -2.1%N/A8.2 $9.81 6/30/202410,320,000 shares $84.83 million -23.1%N/A8.2 $8.22 6/15/202413,414,700 shares $96.18 million -0.4%N/A11 $7.17 5/31/202413,470,000 shares $99.95 million +0.2%N/A11.3 $7.42 5/15/202413,440,000 shares $91.39 million +4.9%N/A11 $6.80 4/30/202412,810,000 shares $70.84 million +8.6%N/A10.3 $5.53 4/15/202411,800,000 shares $74.58 million +11.3%N/A9.9 $6.32 3/31/202410,600,000 shares $81.73 million +5.3%N/A8.8 $7.71 3/15/202410,070,000 shares $75.42 million -1.9%N/A8.2 $7.49 2/29/202410,260,000 shares $77.57 million +5.1%N/A7.5 $7.56 2/15/20249,760,000 shares $85.30 million -1.7%N/A6.7 $8.74 1/31/20249,930,000 shares $88.67 million +2.3%N/A6.3 $8.93 1/15/20249,710,000 shares $92.54 million -2.1%N/A5.8 $9.53 12/31/20239,920,000 shares $89.18 million +2.9%N/A5.9 $8.99 12/15/20239,640,000 shares $83.48 million -3.1%N/A5.8 $8.66 11/30/20239,950,000 shares $62.49 million -6.7%N/A5 $6.28 11/15/202310,660,000 shares $65.77 million +21.0%N/A5.9 $6.17 10/31/20238,810,000 shares $57.09 million +0.5%N/A5.2 $6.48 10/15/20238,770,000 shares $62.27 million +4.2%N/A5.6 $7.10 9/30/20238,420,000 shares $75.27 million -6.9%N/A5.8 $8.94 9/15/20239,040,000 shares $123.76 million +5.7%N/A6.7 $13.69$19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>> 8/31/20238,550,000 shares $122.09 million +5.6%N/A8.3 $14.28 8/15/20238,100,000 shares $123.12 million +0.4%N/A7.6 $15.20 7/31/20238,070,000 shares $138.72 million -2.7%N/A7.3 $17.19 7/15/20238,290,000 shares $126.92 million -2.5%N/A6.5 $15.31 6/30/20238,500,000 shares $130.56 million +11.0%N/A6.3 $15.36 6/15/20237,660,000 shares $131.75 million +4.9%N/A5.4 $17.20 5/31/20237,300,000 shares $130.60 million -3.2%N/A5.4 $17.89 5/15/20237,540,000 shares $123.20 million -4.1%N/A4.7 $16.34 4/30/20237,860,000 shares $169.54 million -3.7%N/A4.7 $21.57 4/15/20238,160,000 shares $165.81 million -4.5%N/A5.6 $20.32 3/31/20238,540,000 shares $192.06 million +14.8%N/A5.7 $22.49 3/15/20237,440,000 shares $158.25 million -1.6%N/A5.4 $21.27 2/28/20237,560,000 shares $167.53 million +9.9%N/A5.7 $22.16 2/15/20236,880,000 shares $138.43 million -7.7%N/A5.8 $20.12 1/31/20237,450,000 shares $166.88 million -0.9%N/A8.8 $22.40 1/15/20237,520,000 shares $152.81 million -10.3%N/A9.1 $20.32 12/30/20228,380,000 shares $176.23 million +3.1%N/A10 $21.03 12/15/20228,130,000 shares $150.41 million -1.2%N/A9.7 $18.50 11/30/20228,230,000 shares $165.67 million +5.9%N/A10.6 $20.13 11/15/20227,770,000 shares $167.13 million -1.2%N/A10.4 $21.51 10/31/20227,860,000 shares $170.40 million +23.0%13.0%10.9 $21.68 10/15/20226,390,000 shares $132.15 million -6.2%10.6%8.4 $20.68 9/30/20226,810,000 shares $167.80 million +3.0%11.3%10.3 $24.64 9/15/20226,610,000 shares $179.79 million -0.5%11.0%9.9 $27.20 8/31/20226,640,000 shares $177.69 million -10.2%11.1%9 $26.76 8/15/20227,390,000 shares $211.28 million +7.9%12.3%9.7 $28.59 7/31/20226,850,000 shares $161.25 million +2.4%11.5%7.9 $23.54 7/15/20226,690,000 shares $163.97 million -5.0%11.2%8.4 $24.51 6/30/20227,040,000 shares $170.58 million +6.2%11.8%8.6 $24.23 6/15/20226,630,000 shares $160.18 million -10.4%11.1%8 $24.16 5/31/20227,400,000 shares $172.49 million -12.6%12.4%8.9 $23.31 5/15/20228,470,000 shares $187.86 million +3.7%14.2%9.7 $22.18 4/30/20228,170,000 shares $205.31 million +14.1%13.8%10.5 $25.13 4/15/20227,160,000 shares $212.22 million +0.7%12.1%9.3 $29.64 3/31/20227,110,000 shares $183.22 million -6.5%12.0%9.8 $25.77 3/15/20227,600,000 shares $181.72 million +29.3%12.8%11.5 $23.91 2/28/20225,880,000 shares $160.29 million -1.7%10.0%9.1 $27.26 2/15/20225,980,000 shares $171.39 million +11.4%10.5%11 $28.66 1/31/20225,370,000 shares $147.68 million +8.5%9.3%10.6 $27.50 1/15/20224,950,000 shares $136.32 million -15.5%8.5%9.3 $27.54 12/31/20215,860,000 shares $181.89 million -6.4%N/A0 $31.04 12/15/20216,260,000 shares $182.48 million +0.6%10.8%11.6 $29.15 11/30/20216,220,000 shares $177.58 million +3.0%10.7%10.5 $28.55 11/15/20216,040,000 shares $177.39 million -1.2%10.4%9.7 $29.37 10/29/20216,110,000 shares $176.03 million +0.5%10.1%5 $28.81 10/15/20216,080,000 shares $148.96 million -6.9%10.2%5.1 $24.50 9/30/20216,530,000 shares $158.35 million -5.6%10.9%5.4 $24.25 9/15/20216,920,000 shares $162.83 million -3.1%11.5%5.4 $23.53 8/31/20217,140,000 shares $155.87 million +6.7%11.9%5.5 $21.83 8/13/20216,690,000 shares $103.36 million -1.6%11.2%4.9 $15.45$19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>> 7/30/20216,800,000 shares $93.50 million +2.6%11.4%8.3 $13.75 7/15/20216,630,000 shares $90.83 million -1.5%11.1%8 $13.70 6/30/20216,730,000 shares $98.19 million +23.0%11.3%8.3 $14.59 6/15/20215,470,000 shares $81.67 million +19.4%9.2%7.5 $14.93 5/28/20214,580,000 shares $69.48 million -0.4%7.7%7 $15.17 5/14/20214,600,000 shares $86.94 million -3.2%7.7%8.7 $18.90 4/30/20214,750,000 shares $117.85 million -1.5%8.0%8.2 $24.81 4/15/20214,820,000 shares $122.48 million -6.4%8.1%7.7 $25.41 3/31/20215,150,000 shares $125.25 million +20.9%8.6%8.3 $24.32 3/15/20214,260,000 shares $122.43 million +3.2%7.2%6.9 $28.74 2/26/20214,130,000 shares $122.66 million -1.7%7.0%6.9 $29.70 2/12/20214,200,000 shares $116.72 million -0.7%7.4%7.3 $27.79 1/29/20214,230,000 shares $109.09 million -2.8%8.4%8.9 $25.79 1/15/20214,350,000 shares $126.67 million No Change8.6%11.1 $29.12 TVTX Short Interest - Frequently Asked Questions What is Travere Therapeutics' current short interest? Short interest is the volume of Travere Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 10,640,000 shares of TVTX short. Learn More on Travere Therapeutics' current short interest. What is a good short interest ratio for Travere Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TVTX shares currently have a short interest ratio of 6.0. Learn More on Travere Therapeutics's short interest ratio. Which institutional investors are shorting Travere Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Travere Therapeutics: Jane Street Group LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Travere Therapeutics' short interest increasing or decreasing? Travere Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 10,640,000 shares, a decline of 3.7% from the previous total of 11,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Travere Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Travere Therapeutics: Verona Pharma plc (9.87%), TG Therapeutics, Inc. (14.56%), Grifols, S.A. (1.26%), Lantheus Holdings, Inc. (10.28%), Legend Biotech Co. (3.67%), Axsome Therapeutics, Inc. (8.53%), Nuvalent, Inc. (13.62%), ADMA Biologics, Inc. (5.17%), Vaxcyte, Inc. (9.33%), Rhythm Pharmaceuticals, Inc. (7.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Travere Therapeutics stock? Short selling TVTX is an investing strategy that aims to generate trading profit from Travere Therapeutics as its price is falling. TVTX shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Travere Therapeutics? A short squeeze for Travere Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TVTX, which in turn drives the price of the stock up even further. How often is Travere Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TVTX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Verona Pharma Short Interest Data TG Therapeutics Short Interest Data Grifols Short Interest Data Lantheus Short Interest Data Legend Biotech Short Interest Data Axsome Therapeutics Short Interest Data Nuvalent Short Interest Data ADMA Biologics Short Interest Data Vaxcyte Short Interest Data Rhythm Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TVTX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Makes Major Crypto AnnouncementYou Won’t Get a Second Chance at This Entry The crypto comeback isn't coming—it's already here. And one ...Crypto 101 Media | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TVTX Stock Free TVTX Stock Alerts